Annovis Bio, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $7.5M | $8.1M |
| FY2021 | — | $44.5M | $45.7M |
| FY2022 | — | $42.7M | $42.7M |
| FY2023 | — | $-7.8M | $5.8M |
| FY2024 | — | $9.3M | $10.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $7.5M | $8.1M |
| FY2021 | — | $44.5M | $45.7M |
| FY2022 | — | $42.7M | $42.7M |
| FY2023 | — | $-7.8M | $5.8M |
| FY2024 | — | $9.3M | $10.6M |